News
Insights from analysts' 12-month price targets are revealed, presenting an average target of $51.3, a high estimate of $61.00, and a low estimate of $31.00. A 14.64% drop is evident in the current ...
3d
Pharmaceutical Technology on MSNBluebird bio reaffirms Carlyle deal as Ayrmid misses deadlineBluebird has reaffirmed its support for a proposed acquisition after Ayrmid failed to deliver a binding offer by the extended ...
Uncanny yet tender sculptures that speak to their creator's own mortality pop up at Altman Siegel Pacific Heights.
Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.
An exhibition at London’s National Portrait Gallery spotlights The Face magazine’s daring style and era-defining image-making ...
FDA accepts Regeneron's sBLA for Eylea HD in RVO with priority review; QUASAR data supports monthly dosing, target action date set for August 2025.
Forbes contributors publish independent expert analyses and insights. Tony Bradley covers the intersection of tech and entertainment.
Let's get started by uploading a starter image. To do this, double-click on the plus icon at the bottom of the Discord screen ...
For a detailed step-by-step explanation of attachments, see the Attachments Tutorial. For describing directions, faces, edges, and corners the library provides a set of shortcuts all based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results